Coronary Artery Disease
📧 Sign up to get email alerts when something new happens for Coronary Artery Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: Use of Flozins (Empagliflozin/Dapagliflozin) for Prevention of AKI
A clinical trial in recruitment evaluating FLOZINS (empagliflozin and dapagliflozin) to prevent acute kidney injury in patients with coronar…
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: Adding Lidocaine to Custodiol Mixture [Phase 4]
A Phase 4 clinical trial is evaluating the addition of lidocaine to the Custodiol cardioplegia solution for patients with coronary artery di…
-
CLINICAL_TRIALS research · 2025-11-13Clinical Trial Update: Clinical Evaluation of Radiation Reduction for Optimized Safety
A clinical trial to evaluate radiation reduction for safer imaging in people with coronary artery disease and myocardial infarction. The stu…
-
CLINICAL_TRIALS trial_result · 2025-11-10Clinical Trial Update: Safety Evaluation of Intracoronary Infusion of Extracellular Vesicles in Patients Following Coronary Stent Implantation [Phase 1]
This Phase 1 safety study evaluated intracoronary infusion of extracellular vesicles in patients after coronary stent implantation; the tria…
-
CLINICAL_TRIALS trial_result · 2025-11-10Clinical Trial Update: Multicenter Study of Silent Myocardial Ischemia (MSSMI)
This clinical trial update reports the completion of a multicenter study evaluating silent myocardial ischemia (MSSMI) sponsored by the Univ…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-11-06Clinical Trial Update: Evaluation of a Novel Non-Invasive Automated Fractional Flow Reserve Software System in Patients With Coronary Artery Disease
A completed clinical trial evaluating a novel non-invasive automated fractional flow reserve software for patients with coronary artery dise…
-
CLINICAL_TRIALS trial_result · 2025-11-06Clinical Trial Update: Role of Stress CMR in Predicting Adverse Clinical Events in Patients With Known or Suspected IHD
The document notes the completion of a study evaluating whether Stress Cardiac Magnetic Resonance imaging can predict adverse clinical event…
-
CLINICAL_TRIALS research · 2025-11-05Clinical Trial Update: Fractional Flow Reserve and Instantaneous Free-wave Ratio Revascularization Strategies in Women
A clinical trial evaluating fractional flow reserve and instantaneous free-wave ratio–guided revascularization in women; currently enrolling…
-
EMA approval · 2025-11-05EMA Authorised: Rivaroxaban Viatris (previously Rivaroxaban Mylan) (rivaroxaban) — Viatris Limited
The EMA authorised Viatris Limited to market rivaroxaban (brand name Rivaroxaban Viatris), expanding access to this anticoagulant as a gener…
-
CLINICAL_TRIALS trial_result · 2025-11-05Clinical Trial Update: Balloon Lithoplasty for Preparation of Severely Calcified Coronary Lesions [NA]
This clinical trial update reports results for balloon lithoplasty as a preparation method for severely calcified coronary lesions prior to …
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: Dual Antiplatelet Therapy Escalation From Standard-dose Clopidogrel to Low-Dose Prasugrel in Patients With High Bleeding and Ischemic Risk Undergoing PCI: A Prospective, Randomized Pharmacodynamic Study (TAILOR-BLEED-2) [Phase 4]
Phase 4 randomized pharmacodynamic study evaluating escalation from standard-dose clopidogrel to low-dose prasugrel in patients undergoing P…
-
CLINICAL_TRIALS research · 2025-10-29Clinical Trial Update: Virtue® SAB in the Treatment of Coronary ISR Trial [NA]
This entry reports that the Virtue SAB trial from Orchestra BioMed is currently recruiting to evaluate treatment of in-stent restenosis in p…
-
FDA approval · 2025-10-28FDA Approved: TICAGRELOR — Original Application (BIONPHARMA INC.)
FDA approved an original application for ticagrelor from Bionpharma Inc., making a generic version of this antiplatelet medication available…
-
FDA approval · 2025-10-28FDA Approved: TICAGRELOR — Original Application (Dr. Reddys Laboratories Inc)
FDA approved Dr. Reddy's Laboratories' original application for ticagrelor as a generic version of the antiplatelet drug, expanding access t…
-
FDA approval · 2025-10-28FDA Approved: TICAGRELOR — Original Application (Apotex Corp.)
FDA approved Apotex Corp.'s original application for a ticagrelor generic.
-
CLINICAL_TRIALS trial_result · 2025-10-24Clinical Trial Update: Outcomes of Surgically Ineligible Patients With Multivessel CAD
This completed clinical trial reports outcomes for patients with multivessel coronary artery disease who were surgically ineligible. The spo…
-
CLINICAL_TRIALS research · 2025-10-23Clinical Trial Update: CaRi-Heart Assessment of Risk and Evaluation of Inflammation in Coronary CT Angiography (CARE-CCTA) [NA]
A clinical trial called CARE-CCTA by Corazon Medical PC is evaluating risk assessment and inflammation in coronary CT angiography for corona…
-
CLINICAL_TRIALS research · 2025-10-22Clinical Trial Update: Study to Determine the Clinical Significance of Intravascular OCT-NIRAF [NA]
A clinical study sponsored by Massachusetts General Hospital is enrolling by invitation to determine the clinical significance of intravascu…
-
CLINICAL_TRIALS research · 2025-10-16Clinical Trial Update: Is Our Microbiome a Predictor of Cardiac Risk
A Mayo Clinic-sponsored clinical trial related to the gut microbiome and cardiac risk is currently enrolling by invitation for patients with…
-
CLINICAL_TRIALS research · 2025-10-14Clinical Trial Update: AI DErived Plaque Quantification: CCTA and AI-QCPA for Determining Effective CAD Management
A clinical trial evaluating AI-derived plaque quantification using coronary CT angiography (CCTA) and AI-QCPA to inform coronary artery dise…
-
CLINICAL_TRIALS research · 2025-10-14Clinical Trial Update: PAtient Similarity for Decision-Making in Prevention of Cardiovascular Toxicity (PACT): A Feasibility Study
This feasibility study evaluates using patient similarity to support decision-making in preventing cardiovascular toxicity.
-
CLINICAL_TRIALS research · 2025-10-09Clinical Trial Update: Intravascular Lithotripsy With or Without Rotational Atherectomy for Coronary Calcified Nodule Treatment [NA]
A clinical trial update indicating recruitment for a study comparing intravascular lithotripsy with or without rotational atherectomy to tre…
-
CLINICAL_TRIALS research · 2025-10-08Clinical Trial Update: Coronary CT Angiogram - Prognostic Value of Adverse Plaque Features in Guiding Treatment (CT-PLAQUE)
The CT-PLAQUE trial investigates whether adverse plaque features seen on coronary CT angiography can predict prognosis and guide treatment, …
-
CLINICAL_TRIALS research · 2025-10-08Clinical Trial Update: Virtual Diabetes Group Visits Across Health Systems [Phase 2]
Phase 2 clinical trial evaluating virtual diabetes group visits across health systems for adults with type 2 diabetes and hypertension, with…
-
CLINICAL_TRIALS research · 2025-10-08Clinical Trial Update: Prevent Cardiac Surgery Associated AKI Trial [Phase 2]
George Washington University is conducting a Phase 2 clinical trial to prevent cardiac surgery-associated acute kidney injury and is current…